Senseonics enters $25M private placement with Abbott; terminates ATM program

Senseonics Holdings, Inc.

Up to $25M of common stock sold to Abbott at public offering price, closing within 2 days after public offering.
Abbott receives info rights on Gemini/Freedom products and exclusive negotiation period for strategic transactions until 2032 or FDA clearance of Freedom.
Company terminates Goldman Sachs ATM equity distribution agreement in connection with proposed public offering.
Private placement price equals per-share price of concurrent public offering, capped at 4.99% beneficial ownership.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.